Pharmacological Treatment of Presbyopia Using Pilocarpine 1.25% Eye Drops
Purpose: To assess the efficiency and safety of pilocarpine eye drop 1.25% analogue (IRPilo) in comparison with its original brand-name drug (Vuity). Methods: In this non-randomized comparative study, 75 patients with presbyopia aged 40 to 60 years were enrolled. The right eyes of these patients r...
Saved in:
Main Authors: | Seyed Abolghasem Mousavi, Zhale Rajavi, Hamideh Sabbaghi, Saeid Abdi, Nafeeseh Montazerin, Bahareh Kheiri, Azadeh Haseli- Monfared, Kourosh Sheibani, Hemn Baghban Jaldian |
---|---|
Format: | Article |
Language: | English |
Published: |
Knowledge E
2024-12-01
|
Series: | Journal of Ophthalmic & Vision Research |
Subjects: | |
Online Access: | https://knepublishing.com/index.php/JOVR/article/view/14578 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Psychological empowerment after presbyopia correction: A narrative from Zanzibari women and men
by: Christine Graham, et al.
Published: (2025-04-01) -
Improvement of Presbyopia, Dry Eye, Intraocular Pressure, and Near Vision Through Cassiae Tea Consumption
by: Mei Fan, et al.
Published: (2024-12-01) -
Job Satisfaction among
Ophthalmologists in Iran
by: Hamideh Sabbaghi, et al.
Published: (2022-11-01) -
Editorial - New Sight for Old: Commentary On the Use of Pilocarpine for Presbyopia
by: Cameron F. Parsa
Published: (2024-12-01) -
Is the convergence insufficiency symptom survey applicable to elderly individuals?
by: Saeid Abdi, et al.
Published: (2025-01-01)